期刊论文详细信息
IJU Case Reports
Rupture of liver metastasis in high-volume metastatic prostate cancer patient on androgen deprivation therapy combined with upfront docetaxel chemotherapy
article
Kenichi Hata1  Masatoshi Tanaka1  Kazuhiro Takahashi1  Takahiro Kimura3 
[1] Department of Urology, Atsugi City Hospital;Contribution: Data curation;Department of Urology, Jikei University School of Medicine;Contribution: Supervision
关键词: androgen deprivation;    docetaxel;    hepatorrhexis;    liver metastasis;    prostate cancer;   
DOI  :  10.1002/iju5.12512
学科分类:社会科学、人文和艺术(综合)
来源: Wiley
PDF
【 摘 要 】

Introduction Recent studies have indicated an improvement in the survival rate of patients using docetaxel in addition to androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer. Hepatorrhexis, characterized by the rupture of the liver, is a rare complication associated with chemotherapies. We report a case of hepatic metastases rupture during androgen deprivation therapy combined with upfront docetaxel chemotherapy. Case presentation A 77-year-old man diagnosed with high-volume metastatic hormone-sensitive prostate cancer received an upfront docetaxel treatment combined with androgen deprivation therapy. Hepatic metastases rupture with substantial hemoperitoneum occurred on the 14th day of the fifth cycle of docetaxel chemotherapy. Transcatheter arterial embolization was performed; however, despite receiving optimal supportive care, the patient died. Conclusion The addition of upfront docetaxel to androgen deprivation therapy may be effective in patients with high-volume metastatic hormone-sensitive prostate cancer; however, strict observation is required to monitor for the occurrence of rare complications, including hepatorrhexis.

【 授权许可】

CC BY|CC BY-NC|CC BY-NC-ND   

【 预 览 】
附件列表
Files Size Format View
RO202302050005636ZK.pdf 447KB PDF download
  文献评价指标  
  下载次数:1次 浏览次数:1次